Gadolinium News and Research

RSS
Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

NIH funds CWRU to investigate new imaging approach for diagnosing peripheral arterial disease

NIH funds CWRU to investigate new imaging approach for diagnosing peripheral arterial disease

Left atrial fibrosis may indicate high risk of arrhythmias in trained endurance athletes

Left atrial fibrosis may indicate high risk of arrhythmias in trained endurance athletes

Researchers develop new system for effective cancer diagnosis and treatment

Researchers develop new system for effective cancer diagnosis and treatment

Scientists explore ways for drug therapies to reach deadly brain tumors

Scientists explore ways for drug therapies to reach deadly brain tumors

Researchers study use of MRI-guided focused ultrasound to open blood-brain barrier

Researchers study use of MRI-guided focused ultrasound to open blood-brain barrier

Study: Gadolinium deposition in brain not associated with dosage

Study: Gadolinium deposition in brain not associated with dosage

Researchers discover substance that could lead to cheaper and smaller MRI machines

Researchers discover substance that could lead to cheaper and smaller MRI machines

Study confirms no survival benefit of adding SIRT to standard treatment for liver cancer

Study confirms no survival benefit of adding SIRT to standard treatment for liver cancer

Alternative MRI contrast agent shows promising results in NIH study

Alternative MRI contrast agent shows promising results in NIH study

New five-minute procedure to scan blood vessels offers hope for claustrophobic patients

New five-minute procedure to scan blood vessels offers hope for claustrophobic patients

MGH researchers develop potential alternative to gadolinium-based MRI contrast agents

MGH researchers develop potential alternative to gadolinium-based MRI contrast agents

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

So much care it hurts: Unneeded scans, therapy, surgery only add to patients’ ills

So much care it hurts: Unneeded scans, therapy, surgery only add to patients’ ills

New MRI contrast agent differentiates between aggressive and slow-growing breast cancers

New MRI contrast agent differentiates between aggressive and slow-growing breast cancers

Preclinical research using 1 Tesla desktop MRI

Preclinical research using 1 Tesla desktop MRI

New multicolor MRI approach could aid disease diagnosis

New multicolor MRI approach could aid disease diagnosis

Gadolinium-based MRI contrast agents deposit in the brain

Gadolinium-based MRI contrast agents deposit in the brain

Experiments in big animals show efficacy of new non-toxic MRI contrast agent

Experiments in big animals show efficacy of new non-toxic MRI contrast agent